| 000 | 01315 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517223455.0 | ||
| 264 | 0 | _c20190906 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1365-2230 | ||
| 024 | 7 |
_a10.1111/ced.13694 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbdelmaksoud, A | |
| 245 | 0 | 0 |
_aAciclovir for treatment of pityriasis lichenoides? _h[electronic resource] |
| 260 |
_bClinical and experimental dermatology _cJan 2019 |
||
| 300 |
_a64 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAcyclovir _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 |
_aChemokines _xmetabolism |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
| 650 | 0 | 4 |
_aHerpesvirus 7, Human _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratinocytes _xpathology |
| 650 | 0 | 4 |
_aLewis X Antigen _xanalogs & derivatives |
| 650 | 0 | 4 |
_aOligosaccharides _xmetabolism |
| 650 | 0 | 4 |
_aPityriasis Lichenoides _xdrug therapy |
| 650 | 0 | 4 |
_aSialyl Lewis X Antigen _xanalogs & derivatives |
| 650 | 0 | 4 |
_aT-Lymphocytes _xmetabolism |
| 773 | 0 |
_tClinical and experimental dermatology _gvol. 44 _gno. 1 _gp. 64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ced.13694 _zAvailable from publisher's website |
| 999 |
_c28550488 _d28550488 |
||